oncology

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Nila Kartika Wati September 9, 2025

By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...

From Pandemic Giant to Oncology Pioneer: BioNTech’s High-Stakes Strategic Pivot from-pandemic-giant-to-oncology-pioneer-biontechs-high-stakes-strategic-pivot

Nana Wu August 22, 2025

Introduction The biotechnology landscape is defined by cycles of explosive growth and sobering consolidation, yet few trajectories...

Unraveling the Colorectal Cancer Paradox: A Breakthrough in Immunotherapy Research unraveling-the-colorectal-cancer-paradox-a-breakthrough-in-immunotherapy-research

Raul Delapena Setiawan August 14, 2025

NEW YORK, NY – For decades, the intricate dance between the immune system and cancer has presented...

Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation modernas-mrna-flu-vaccine-shows-superior-efficacy-navigates-fda-review-after-initial-hesitation

Ammar Sabilarrohman August 13, 2025

A groundbreaking Phase III trial has demonstrated that Moderna’s experimental mRNA-based flu vaccine, mRNA-1010, significantly outperforms a...

Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities japan-faces-uphill-battle-to-achieve-lung-cancer-screening-goals-amidst-persistent-regional-and-gender-disparities

Raul Delapena Setiawan August 13, 2025

Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening...

From Spreadsheets to Strategy: How AI is Overhauling the $5.9 Million Clinical Data Bottleneck from-spreadsheets-to-strategy-how-ai-is-overhauling-the-5-9-million-clinical-data-bottleneck

Pevita Pearce August 4, 2025

In the high-stakes world of pharmaceutical development, where a single Phase 3 clinical trial can represent billions...

You may have missed